Life Liabilities And Stockholders Equity from 2010 to 2024
| LABS Stock | 38.60 0.10 0.26% |
Liabilities And Stockholders Equity | First Reported 2010-12-31 | Previous Quarter 410.7 M | Current Value 447.3 M | Quarterly Volatility 31.6 M |
Check Life Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Life Science's main balance sheet or income statement drivers, such as Interest Income of 2.6 M, Interest Expense of 11.6 M or Selling General Administrative of 5.8 M, as well as many indicators such as . Life financial statements analysis is a perfect complement when working with Life Science Valuation or Volatility modules.
Life |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.